The global COPD market is estimated to currently be worth $11 3 billion, and is forecast to reach a value of $15 6 billion by 2019 Much of this growth will be fuelled by a high number of new, more efficacious...

The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16 6 billion in 2012 to a projected value of $21 6 billion in 2019 This growth...